Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »Novavax stock jumps on vaccinated deal with South Korean firm
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »Modern stock pops to agree to sell at least 100 million COVID-19 vaccine doses to US government
Moderna Inc. MRNA, -4.22% announced Tuesday afternoon that it has reached an agreement to sell 100 million doses of its research vaccine for COVID-19 to the U.S. government for more than $ 1.5 billion. “Breaking: Moderna announces delivery agreement with US government to secure an initial $ 100 million dose …
Read More »Johnson & Johnson begins trial of one-dose Covid-19 vaccine
Text size Johnson & Johnson became the third western biopharmaceutical company to start a new test of its Covid-19 vaccine this week, but with one difference: in a surprise announcement Thursday morning, the company said it would test its vaccine in a format single dose. Moderna (MRNA) and Pfizer (PFE) …
Read More »Pharmacists Compete to Build Covid-19 Vaccine Supply Chains
Pharmaceutical companies competing to develop coronavirus vaccines are already working behind the scenes to build the supply chains necessary to deliver their drugs to billions of people as quickly as possible. To meet global demand once a vaccine is approved, a complicated and high-risk supply chain would be put in …
Read More »